Physician profile
Polly C James
NPI 1801286885
$1,345.65
in general payments reported to CMS, 2019-2025
15 companies · $17.10 in 2025
The $17.10 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $252 · 2022: $338 · 2023: $509 · 2024: $230 · 2025: $17.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $410.02 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $181.94 | 2021-2024 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $146.16 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $115.39 | 2021-2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.61 | 2021-2023 | Jardiance |
| Lilly USA, LLC | $70.39 | 2022-2025 | Mounjaro, Zepbound |
| Amgen INC. | $66.73 | 2022-2023 | Otezla, Repatha |
| Corcept Therapeutics | $56.49 | 2023 | Korlym |
| Abbvie INC. | $53.55 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.41 | 2021-2022 | |
| Exact Sciences Corporation | $36.48 | 2023-2024 | Cologuard Collection Kit |
| Abbott Laboratories | $22.39 | 2023 | Freestyle Libre 2 |
| Almatica Pharma LLC | $20.20 | 2022 | |
| Pfizer INC. | $17.48 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Polly James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.